Pharmacy and medication events
In 2020, the #farmaCSC debate cycle on Public Management of innovative medicines will consist of two sessions, the first to address hospital pharmacy and Covid, and the second on the treatment of migraine.
In 2019, the cycle of debates #farmaCSC on Public Management of innovative medicines is carried out with sessions in which the best strategies for access to medicines are addressed in four areas: mental health, neurodegenerative diseases, anti-infectives and advanced therapies.
In 2018, the cycle of debates #farmaCSC on Public Management of innovative medicines was carried out with sessions in which the best strategies for access to medicines were addressed in four areas: anticipation, access management, innovative purchase and health outcomes, and focusing each session on a therapeutic area: oncology, hematology, autoimmune diseases, chronic diseases and minority diseases.
The cycle of debates #farmaCSC on Public Management of Innovative Medicines held its first edition in 2017 with the aim of identifying innovations in the management of access to innovative medicines and to propose a debate that proposes solutions to the challenges that arise regarding evaluation, financing and purchasing as facilitating tools for access management. The cycle of sessions allowed to know first hand the analysis and vision of the main decision-makers and opinion leaders in Catalonia in this topic and to relate with experts and other professionals involved in the management of access to medicines.